ResMed has agreed to sell MatrixCare, its home-health and senior-care software business, to Frazier Healthcare Partners for $490 million in cash, according to available reporting. The transaction would transfer ownership of the software unit that ResMed has operated for years. The deal is structured to allow ResMed to divest MatrixCare and direct attention toward its remaining medical-device business, which it describes as its core focus. MatrixCare is characterized in coverage as a sizable software operation serving home-health and senior-care settings. The reporting provided does not include details on timing, regulatory approvals, or whether the agreement is subject to specific conditions, nor does it outline how the proceeds will be used. The information also does not specify whether any employees or related assets are included beyond the MatrixCare business itself. Overall, the disclosed terms center on the acquisition price and cash payment by Frazier for the MatrixCare unit.
ResMed agrees to sell MatrixCare to Frazier Healthcare Partners for $490 million
ResMed has agreed to sell MatrixCare, its home-health and senior-care software business, to Frazier Healthcare Partners for $490 million in cash, according to available reporting. The transaction woul...
- ResMed agrees to sell MatrixCare, its home-health and senior-care software business.
- The buyer is private equity firm Frazier Healthcare Partners.
- The purchase price is $490 million, paid in cash.
- The deal involves ResMed divesting a software unit it has owned for years.
- The move is described as enabling ResMed to focus on its remaining medical-device business.
ResMed has agreed to sell MatrixCare, its home-health and senior-care software business, to the private equity firm Frazier Healthcare Partners for $490m in cash. The deal lets the medical-device maker part with a unit it had owned for years to focus on the machines that remain its core. MatrixCare is a decent-sized business in its […] This story continues at The Next Web
3 hours ago
U of T and McMaster announce new life sciences venture capital fund with Genesys Capital
The University of Toronto and McMaster University announce a new early-stage venture capital fund aimed at backing Ontar...
Severn Trent avoids Ofwat fine after wastewater and sewage breaches
Water company Severn Trent is not fined by the industry regulator Ofwat despite being found to have committed “serious”...
U.S. trade deficit rises in May to a 14-month high on stronger capital goods imports
The U.S. trade deficit widens in May to a 14-month high, driven primarily by higher imports linked to capital goods purc...